An integrated proteomics and bioinformatics analyses of hepatitis B virus X interacting proteins and identification of a novel interactor apoA-I

Journal of Proteomics

Volumn 84, Issue , 2013, Pages 92-105

  Zhang, Tao ^a,b   Xie, Na ^a   He, Weifeng ^c   Liu, Rui ^a   Lei, Yunlong ^a   Chen, Yi ^a   Tang, Hong ^a   Liu, Bo ^a   Huang, Canhua ^a   Wei, Yuquan ^a  

^a SICHUAN UNIVERSITY   (China)

^b CHENGDU MEDICAL COLLEGE   (China)

^c THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

ApoA I; HBV secretion; Hepatitis B virus X protein (HBx) interactome; Protein protein interaction (PPI) network

Indexed keywords

APOLIPOPROTEIN A1; CHOLESTEROL; HEPATITIS B VIRUS X PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; BIOINFORMATICS; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MASS SPECTROMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; PROTEOMICS;

ANIMALS; APOLIPOPROTEIN A-I; CHOLESTEROL; COMPUTATIONAL BIOLOGY; GENE EXPRESSION REGULATION; HEK293 CELLS; HEP G2 CELLS; HEPATITIS B VIRUS; HUMANS; PROTEOMICS; TRANS-ACTIVATORS; VIRUS SHEDDING;

EID: 84877136180     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2013.03.028     Document Type: Article

References (55)

1. Mhamdi M., Funk A., Hohenberg H., Will H., Sirma H. Assembly and budding of a hepatitis B virus is mediated by a novel type of intracellular vesicles. Hepatology 2007, 46:95-106.
2. Gearhart T.L., Bouchard M.J. Replication of the hepatitis B virus requires a calcium-dependent HBx-induced G1 phase arrest of hepatocytes. Virology 2010, 407:14-25.
3. Hu L., Chen L., Li L., Sun H., Yang G., Chang Y., et al. Hepatitis B virus X protein enhances cisplatin-induced hepatotoxicity via a mechanism involving degradation of Mcl-1. J Virol 2011, 85:3214-3228.
4. Sung W.K., Lu Y., Lee C.W., Zhang D., Ronaghi M., Lee C.G. Deregulated direct targets of the hepatitis B virus (HBV) protein, HBx, identified through chromatin immunoprecipitation and expression microarray profiling. J Biol Chem 2009, 284:21941-21954.
5. Jaitovich-Groisman I., Benlimame N., Slagle B.L., Perez M.H., Alpert L., Song D.J., et al. Transcriptional regulation of the TFIIH transcription repair components XPB and XPD by the hepatitis B virus x protein in liver cells and transgenic liver tissue. J Biol Chem 2001, 276:14124-14132.
6. Tanaka Y., Kanai F., Ichimura T., Tateishi K., Asaoka Y., Guleng B., et al. The hepatitis B virus X protein enhances AP-1 activation through interaction with Jab1. Oncogene 2006, 25:633-642.
7. Qadri I., Fatima K., Abde L.H.H. Hepatitis B virus X protein impedes the DNA repair via its association with transcription factor, TFIIH. BMC Microbiol 2011, 11:48.
8. Zhang Z., Torii N., Furusaka A., Malayaman N., Hu Z., Liang T.J. Structural and functional characterization of interaction between hepatitis B virus X protein and the proteasome complex. J Biol Chem 2000, 275:15157-15165.
9. Fischer M., Runkel L., Schaller H. HBx protein of hepatitis B virus interacts with the C-terminal portion of a novel human proteasome alpha-subunit. Virus Genes 1995, 10:99-102.
10. Stoffel W. Synthesis, transport, and processing of apolipoproteins of high density lipoproteins. J Lipid Res 1984, 25:1586-1592.
11. Reschly E.J., Sorci-Thomas M.G., Davidson W.S., Meredith S.C., Reardon C.A., Getz G.S. Apolipoprotein A-I alpha -helices 7 and 8 modulate high density lipoprotein subclass distribution. J Biol Chem 2002, 277:9645-9654.
12. Laccotripe M., Makrides S.C., Jonas A., Zannis V.I. The carboxyl-terminal hydrophobic residues of apolipoprotein A-I affect its rate of phospholipid binding and its association with high density lipoprotein. J Biol Chem 1997, 272:17511-17522.
13. Sviridov D., Hoang A., Sawyer W.H., Fidge N.H. Identification of a sequence of apolipoprotein A-I associated with the activation of lecithin:cholesterol acyltransferase. J Biol Chem 2000, 275:19707-19712.
14. Norton P.A., Gong Q., Mehta A.S., Lu X., Block T.M. Hepatitis B virus-mediated changes of apolipoprotein mRNA abundance in cultured hepatoma cells. J Virol 2003, 77:5503-5506.
15. Xie N., Huang K., Zhang T., Lei Y., Liu R., Wang K., et al. Comprehensive proteomic analysis of host cell lipid rafts modified by HBV infection. J Proteomics 2012, 75:725-739.
16. Lei Y., Huang K., Gao C., Lau Q.C., Pan H., Xie K., et al. Proteomics identification of ITGB3 as a key regulator in reactive oxygen species-induced migration and invasion of colorectal cancer cells. Mol Cell Proteomics 2011, 10. [M110 005397].
17. Li J., Liu R., Lei Y., Wang K., Lau Q.C., Xie N., et al. Proteomic analysis revealed association of aberrant ROS signaling with suberoylanilide hydroxamic acid-induced autophagy in Jurkat T-leukemia cells. Autophagy 2010, 6:711-724.
18. Mishra G.R., Suresh M., Kumaran K., Kannabiran N., Suresh S., Bala P., et al. Human protein reference database-2006 update. Nucleic Acids Res 2006, 34:D411-D414.
19. Alfarano C., Andrade C.E., Anthony K., Bahroos N., Bajec M., Bantoft K., et al. The biomolecular interaction network database and related tools 2005 update. Nucleic Acids Res 2005, 33:D418-D424.
20. Kerrien S., Alam-Faruque Y., Aranda B., Bancarz I., Bridge A., Derow C., et al. IntAct-open source resource for molecular interaction data. Nucleic Acids Res 2007, 35:D561-D565.
21. Persico M., Ceol A., Gavrila C., Hoffmann R., Florio A., Cesareni G. HomoMINT: an inferred human network based on orthology mapping of protein interactions discovered in model organisms. BMC Bioinformatics 2005, 6(Suppl. 4):S21.
22. Winter A.G., Wildenhain J., Tyers M. BioGRID REST Service, BiogridPlugin2 and BioGRID WebGraph: new tools for access to interaction data at BioGRID. Bioinformatics 2011, 27:1043-1044.
23. Agarwal S., Deane C.M., Porter M.A., Jones N.S. Revisiting date and party hubs: novel approaches to role assignment in protein interaction networks. PLoS Comput Biol 2010, 6:e1000817.
24. Fu L.L., Yang Y., Xu H.L., Cheng Y., Wen X., Ouyang L., et al. Identification of novel caspase/autophagy-related gene switch to cell fate decisions in breast cancer. Cell Proliferat 2013, 46:67-75.
25. Tian X., Zhao C., Ren J., Ma Z.M., Xie Y.H., Wen Y.M. Gene-expression profiles of a hepatitis B small surface antigen-secreting cell line reveal upregulation of lymphoid enhancer-binding factor 1. J Gen Virol 2007, 88:2966-2976.
26. Zheng Q., Wang X.J. GOEAST: a web-based software toolkit for Gene Ontology enrichment analysis. Nucleic Acids Res 2008, 36:W358-W363.
27. Marti-Renom M.A., Stuart A.C., Fiser A., Sanchez R., Melo F., Sali A. Comparative protein structure modeling of genes and genomes. Annu Rev Biophys Biomol Struct 2000, 29:291-325.
28. Pettersen E.F., Goddard T.D., Huang C.C., Couch G.S., Greenblatt D.M., Meng E.C., et al. UCSF chimera-a visualization system for exploratory research and analysis. J Comput Chem 2004, 25:1605-1612.
29. Wang K., Liu R., Li J., Mao J., Lei Y., Wu J., et al. Quercetin induces protective autophagy in gastric cancer cells: involvement of Akt-mTOR- and hypoxia-induced factor 1alpha-mediated signaling. Autophagy 2011, 7:966-978.
30. Conrad C.C., Talent J.M., Malakowsky C.A., Gracy R.W. Post-electrophoretic identification of oxidized proteins. Biol Proced Online 2000, 2:39-45.
31. Kreeger P.K., Lauffenburger D.A. Cancer systems biology: a network modeling perspective. Carcinogenesis 2010, 31:2-8.
32. Kim J.S., Rho B., Lee T.H., Lee J.M., Kim S.J., Park J.H. The interaction of hepatitis B virus X protein and protein phosphatase type 2 Calpha and its effect on IL-6. Biochem Biophys Res Commun 2006, 351:253-258.
33. Stellberger T., Hauser R., Baiker A., Pothineni V.R., Haas J., Uetz P. Improving the yeast two-hybrid system with permutated fusions proteins: the varicella zoster virus interactome. Proteome Sci 2010, 8:8.
34. Berggard T., Linse S., James P. Methods for the detection and analysis of protein-protein interactions. Proteomics 2007, 7:2833-2842.
35. Detection of protein-protein interactions using the GST fusion protein pull-down technique. Nat Methods 2004, 1:275-276.
36. Tralhao J.G., Roudier J., Morosan S., Giannini C., Tu H., Goulenok C., et al. Paracrine in vivo inhibitory effects of hepatitis B virus X protein (HBx) on liver cell proliferation: an alternative mechanism of HBx-related pathogenesis. Proc Natl Acad Sci U S A 2002, 99:6991-6996.
37. Barabasi A.L., Oltvai Z.N. Network biology: understanding the cell's functional organization. Nat Rev Genet 2004, 5:101-113.
38. Jansen R., Yu H., Greenbaum D., Kluger Y., Krogan N.J., Chung S., et al. A Bayesian networks approach for predicting protein-protein interactions from genomic data. Science 2003, 302:449-453.
39. Ideker T., Krogan N.J. Differential network biology. Mol Syst Biol 2012, 8:565.
40. Yang F., Yin Y., Wang F., Zhang L., Wang Y., Sun S. An altered pattern of liver apolipoprotein A-I isoforms is implicated in male chronic hepatitis B progression. J Proteome Res 2010, 9:134-143.
41. Luo D.X., Cao D.L., Xiong Y., Peng X.H., Liao D.F. A novel model of cholesterol efflux from lipid-loaded cells. Acta Pharmacol Sin 2010, 31:1243-1257.
42. Patient R., Hourioux C., Sizaret P.Y., Trassard S., Sureau C., Roingeard P. Hepatitis B virus subviral envelope particle morphogenesis and intracellular trafficking. J Virol 2007, 81:3842-3851.
43. Imelli N., Meier O., Boucke K., Hemmi S., Greber U.F. Cholesterol is required for endocytosis and endosomal escape of adenovirus type 2. J Virol 2004, 78:3089-3098.
44. Bergt C., Pennathur S., Fu X., Byun J., O'Brien K., McDonald T.O., et al. The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport. Proc Natl Acad Sci U S A 2004, 101:13032-13037.
45. Bhat S., Sorci-Thomas M.G., Tuladhar R., Samuel M.P., Thomas M.J. Conformational adaptation of apolipoprotein A-I to discretely sized phospholipid complexes. Biochemistry 2007, 46:7811-7821.
46. Shao B., Bergt C., Fu X., Green P., Voss J.C., Oda M.N., et al. Tyrosine 192 in apolipoprotein A-I is the major site of nitration and chlorination by myeloperoxidase, but only chlorination markedly impairs ABCA1-dependent cholesterol transport. J Biol Chem 2005, 280:5983-5993.
47. Lee Y.I., Hwang J.M., Im J.H., Kim N.S., Kim D.G., Yu D.Y., et al. Human hepatitis B virus-X protein alters mitochondrial function and physiology in human liver cells. J Biol Chem 2004, 279:15460-15471.
48. Ha H.L., Yu D.Y. HBx-induced reactive oxygen species activates hepatocellular carcinogenesis via dysregulation of PTEN/Akt pathway. World J Gastroenterol 2010, 16:4932-4937.
49. Ajees A.A., Anantharamaiah G.M., Mishra V.K., Hussain M.M., Murthy H.M. Crystal structure of human apolipoprotein A-I: insights into its protective effect against cardiovascular diseases. Proc Natl Acad Sci U S A 2006, 103:2126-2131.
50. Saito H., Dhanasekaran P., Nguyen D., Deridder E., Holvoet P., Lund-Katz S., et al. Alpha-helix formation is required for high affinity binding of human apolipoprotein A-I to lipids. J Biol Chem 2004, 279:20974-20981.
51. Carnemolla R., Ren X., Biswas T.K., Meredith S.C., Reardon C.A., Wang J., et al. The specific amino acid sequence between helices 7 and 8 influences the binding specificity of human apolipoprotein A-I for high density lipoprotein (HDL) subclasses: a potential for HDL preferential generation. J Biol Chem 2008, 283:15779-15788.
52. Saito H., Lund-Katz S., Phillips M.C. Contributions of domain structure and lipid interaction to the functionality of exchangeable human apolipoproteins. Prog Lipid Res 2004, 43:350-380.
53. Sigalov A.B., Stern L.J. Oxidation of methionine residues affects the structure and stability of apolipoprotein A-I in reconstituted high density lipoprotein particles. Chem Phys Lipids 2001, 113:133-146.
54. Mohamadkhani A., Rastgar Jazii F., Sayehmiri K., Jafari-Nejad S., Montaser-Kouhsari L., Poustchi H., et al. Plasma myeloperoxidase activity and apolipoprotein a-1 expression in chronic hepatitis B patients. Arch Iran Med 2011, 14:254-258.
55. Zheng L., Nukuna B., Brennan M.L., Sun M., Goormastic M., Settle M., et al. Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease. J Clin Invest 2004, 114:529-541.